Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, February 24, 2023
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
Eric Joseph Downgraded (CCCC) to Sell and Decreased Target to $5 on, Feb 24th, 2023
Eric Joseph of JP Morgan, Downgraded "C4 Therapeutics, Inc." (CCCC) to Sell and Decreased Target from $15 to $5 on, Feb 24th, 2023.
Eric has made no other calls on CCCC in the last 4 months.
There is 1 other peer that has a rating on CCCC. Out of the 1 peers that are also analyzing CCCC, all agrees with Eric's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Derek Archila of "Wells Fargo" Maintained at Hold with Decreased Target to $9 on, Tuesday, January 3rd, 2023
